A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
about
Childhood immune thrombocytopenia: Clinical presentation and managementB cell depletion in autoimmune disease.Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraRepeated courses of rituximab in chronic ITP: Three different regimens.Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cellsOutcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.ITP: hematology's Cosette from Les Misérables.Successful treatment of refractory idiopathic thrombocytopenic purpura and neutropenia with the monoclonal antibody, rituximabChronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.Rituximab: mechanisms and applications.Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trialB cell reductive therapy with rituximab in the treatment of rheumatoid arthritis.A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.Enteroviral Encephalitis in a Child With CNS Relapse of Burkitt Leukemia Treated With Rituximab.Efficacy and tolerability of old and new drugs used in the treatment of immune thrombocytopenia: Results from a long-term observation in clinical practice.
P2860
Q27023294-365B7104-1C80-4FF1-B66A-FD74FC8FDCC1Q33361142-EF510CDE-0D81-4CDE-9707-2AC3B58C2493Q33369574-B80C4786-13CC-4AD6-8324-AB0ABC28B0BDQ33386117-83F66B12-2D88-4D3E-8BD9-F3016EE3AFCAQ33395970-7A40D9AD-80EC-4FD1-9A25-21C83C52236DQ33401100-8A8A1A9B-65D2-4165-89FD-C1D375D209F7Q33406470-5FCF3C84-A7F3-4B72-BF59-1AA65BD95FB9Q33408154-0448DC68-7DF7-4FBA-B244-F25C6520CA2AQ33434365-3B7B5058-0556-480D-A4A1-DB963309584FQ34462378-497E8BAD-DF24-45BB-BE8C-33ADE8E1EC51Q37144563-64DC1C74-5909-4F77-8BFC-D97D3C6D4E4AQ37586921-C4F8628D-5619-4808-BC64-DB756CF8225EQ41791356-97B9D8EF-B840-46C2-8A4D-C3B5F129BCB4Q47556669-73D0669A-FEEB-4543-9EED-F882404138C0Q55332132-0DFFBB95-01C1-4E23-9FC6-B5734728C2C6
P2860
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@ast
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@en
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@nl
type
label
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@ast
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@en
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@nl
prefLabel
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@ast
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@en
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@nl
P2093
P1433
P1476
A pilot study of the anti-CD20 ...... ctory immune thrombocytopenia.
@en
P2093
Grillo-López AJ
LoBuglio AF
P304
P433
6 Suppl 12
P577
2000-12-01T00:00:00Z